BusinessAbeona Therapeutics Reports Q4 2016 Financial Results and Business HighlightsBy Nasdaq OMXMar 31, 2017, 12:05 PM UTC
BusinessEarth Science Tech, Inc. Expands Marketing Campaign to MassRoots (OTC: MSRT), Natural Awakenings Magazine, and Enhances Product PackagingBy Nasdaq OMXMar 30, 2017, 11:25 AM UTC
BusinessAXIM Biotech Enters Term Sheet Agreement With US API Company to Develop Bioequivalent Product to MarinolBy Nasdaq OMXMar 28, 2017, 1:01 PM UTC
BusinessInvivoscribe Expands Business into Solid Tumors with Assays and Services to Identify and Monitor CAR-T and TCR Immuno-TherapiesBy Nasdaq OMXMar 28, 2017, 10:00 AM UTC
BusinessBeyondSpring Chief Medical Offer to Present on Lead Asset Plinabulin for Chemotherapy-Induced Neutropenia Prevention at BIO-Europe Spring 2017By Nasdaq OMXMar 22, 2017, 12:30 PM UTC
BusinessBeyondSpring Lead Asset Plinabulin's Anti-Cancer Mechanism Accepted for Poster Presentation at the 2017 Keystone Symposia in British ColumbiaBy Nasdaq OMXMar 20, 2017, 12:30 PM UTC
BusinessTonix Pharmaceuticals Announces 1-for-10 Reverse Stock SplitBy Nasdaq OMXMar 16, 2017, 5:00 PM UTC
BusinessOnconova Therapeutics, Inc. to Provide Corporate Update and Full Year 2016 Financial ResultsBy Nasdaq OMXMar 16, 2017, 12:30 PM UTC
